These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 4583583)

  • 1. Ribonucleoprotein antibodies: frequency and clinical significance in systemic lupus erythematosus, scleroderma, and mixed connective tissue disease.
    Parker MD
    J Lab Clin Med; 1973 Nov; 82(5):769-75. PubMed ID: 4583583
    [No Abstract]   [Full Text] [Related]  

  • 2. Association of antibodies to ribonucleoprotein and Sm antigens with mixed connective-tissue disease, systematic lupus erythematosus and other rheumatic diseases.
    Sharp GC; Irvin WS; May CM; Holman HR; McDuffie FC; Hess EV; Schmid FR
    N Engl J Med; 1976 Nov; 295(21):1149-54. PubMed ID: 1086429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Dysimmune rheumatism in Raynaud's syndrome (inflammatory rheumatism, Raynaud's syndrome, speckled antinuclear factors and anti-ribonucleoprotein antibody): a new syndrome?].
    Appelboom T; Kahn MF; Peltier AP; de SEZE S
    Ann Med Interne (Paris); 1974 Nov; 125(11):841-8. PubMed ID: 4218716
    [No Abstract]   [Full Text] [Related]  

  • 4. [Sharp's syndrome: a new entity amongst the connective tissue diseases?].
    Kahn MF; Peltier AP; Appelboom T
    Nouv Presse Med; 1975 Jun; 4(25):1863-5. PubMed ID: 1080278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [DNA-antibodies in patients with lupus erythematosus, scleroderma and blister-forming skin diseases].
    Kerl H; Sandhofer M; Klein G; Altmann H
    Hautarzt; 1975 Jan; 26(1):30-4. PubMed ID: 1090563
    [No Abstract]   [Full Text] [Related]  

  • 6. Significance of anti-ENA, Sm and RNP antibodies in patients with antinuclear antibodies.
    Levo Y; Lotan C
    Isr J Med Sci; 1982 Feb; 18(2):287-9. PubMed ID: 6978327
    [No Abstract]   [Full Text] [Related]  

  • 7. [Chronic gastritis in connective tissue diseases].
    Apostoloff E; Reitzig P; Lisewski G; David H
    Z Gesamte Inn Med; 1971 May; 26(9):Suppl:107-9. PubMed ID: 4943256
    [No Abstract]   [Full Text] [Related]  

  • 8. [Significance of antinuclear antibodies in overlap syndromes. I. Relationship between systemic lupus erythematosus, diffuse scleroderma and dermatomyositis].
    Zitnan D; Rovenský J; Cebecauer L; Hajzok O
    Fysiatr Revmatol Vestn; 1973 Jun; 51(3):152-7. PubMed ID: 4592583
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical characteristics of patients with nuclear antiribonucleoprotein antibodies. Evidence of circulating immunocomplexes in mixed connective tissue disease].
    Rodríguez-Valverde V; Orte Martínez J; Sampedro Alvarez J; Peña Sagredo JL; Sánchez Andrada S
    Med Clin (Barc); 1982 Jun; 79(1):9-15. PubMed ID: 7121111
    [No Abstract]   [Full Text] [Related]  

  • 10. Precipitating antibody to a soluble nuclear antigen "Ki" with specificity for systemic lupus erythematosus.
    Tojo T; Kaburaki J; Hayakawa M; Okamoto T; Tomii M; Homma M
    Ryumachi; 1981; 21 Suppl():129-40. PubMed ID: 6979801
    [No Abstract]   [Full Text] [Related]  

  • 11. [Detection of antinuclear antibodies using HEp-2 cells as nuclear substrates by the indirect immunofluorescent antibody technic].
    Watanabe S; Miyawaki S
    Rinsho Byori; 1987 Jan; 35(1):61-6. PubMed ID: 3550177
    [No Abstract]   [Full Text] [Related]  

  • 12. [Anti-DNA antibodies; results of a new method of detection using the fluorescent antibody technic].
    Kahn MF; Peltier AP; Haim T; Marcheteau M; de Sèze S
    Rev Rhum Mal Osteoartic; 1973 Jun; 40(6):393-8. PubMed ID: 4580290
    [No Abstract]   [Full Text] [Related]  

  • 13. [Demonstration of antinuclear antibodies in the epidermis of patients with progressive systemic sclerosis, generalized lupus erythematosus and dermatomyositis].
    Lamas Robles C; Mejía Arreguín S; Orozco Medina JH; González Mendoza A
    Rev Invest Clin; 1984; 36(2):115-9. PubMed ID: 6385174
    [No Abstract]   [Full Text] [Related]  

  • 14. Characterization of a soluble nuclear ribonucleoprotein antigen reactive with SLE sera.
    Mattioli M; Reichlin M
    J Immunol; 1971 Nov; 107(5):1281-90. PubMed ID: 4330162
    [No Abstract]   [Full Text] [Related]  

  • 15. [Antinuclear antibodies and beta1A concentration in systemic lupus erythematosus and other diseases].
    Monegat JN; Joller-Jemelka HI; Grob PJ
    Schweiz Med Wochenschr; 1974 Nov; 104(45):1614-23. PubMed ID: 4612703
    [No Abstract]   [Full Text] [Related]  

  • 16. Profiles of antibodies to poly(ADP-ribose), left-handed Z-DNA, and other nuclear constituents in systemic lupus erythematosus and progressive systemic sclerosis.
    Kanai Y; Moroi Y; Yokohari R; Goto S
    Princess Takamatsu Symp; 1983; 13():93-100. PubMed ID: 6654833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical usefulness of antibodies to U1snRNP proteins in mixed connective tissue disease and systemic lupus erythematosus.
    Margaux J; Hayem G; Palazzo E; Chazerain P; De Bandt M; Haim T; Kahn MF; Meyer O
    Rev Rhum Engl Ed; 1998 Jun; 65(6):378-86. PubMed ID: 9670329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antinuclear antibodies, antiperinuclear factor and rheumatoid factors in a group of children with collagen diseases].
    Vaccaro R; Rossoni R; Alestra P
    Minerva Pediatr; 1967 Dec; 19(49):2181-6. PubMed ID: 4885636
    [No Abstract]   [Full Text] [Related]  

  • 19. [Serum antinuclear antibodies (in patients with visceral erythematodes, rheumatoid arthritis, progressive systemic sclerosis and discoid erythematodes)].
    Horvat Z
    Acta Med Iugosl; 1970; 24(3):229-40. PubMed ID: 4928076
    [No Abstract]   [Full Text] [Related]  

  • 20. [Humoral and cellular immunity indices in lupus erythematosus and scleroderma].
    Butov IuS; Skripkin IuK; Koshevenko IuN
    Vestn Dermatol Venerol; 1978 Apr; (4):7-11. PubMed ID: 77599
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.